“When we blocked chitinase-like proteins in mice, we were able to reverse some of the damage,” said Dr. Tara Sutherland, lead researcher of the study at the University of Aberdeen. “This suggests a ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for people with asthma, not least of all to have “zero tolerance for asthma ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

Allergen immunotherapy (AIT) had a favorable safety profile in patients with severe allergic asthma, with significant improvements in lung function and reduced emergency department visits. Researchers ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

A joint scientific study conducted by researchers at the Medical Research Institute of New Zealand, in collaboration with Imperial College London, the University of Otago, Starship Children's Hospital ...

Children with mild asthma at low risk for severe exacerbations may not need daily or as-needed ICS, as GINA guidelines recommend.

In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

Among women who never used oral contraceptives or female hormone therapy, no significant link was found between menopause and the odds for asthma, according to data published in The Journal of Allergy ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

Among pediatric patients with intermittent asthma, around one-third did not have significant acute care needs over a 2-year period and dispensed two or fewer albuterol inhalers per year, according to ...